Pediatric Cancer in the News
Q&A With Kimberly Stegmaier, MD, on the 2015 AACR Advances in Pediatric Cancer Research Special Conference
AACR Cancer Research Catalyst Blog Post: Breaking the (Genetic) Code of Pediatric Medulloblastoma
Dr. Andrew Kung Discusses Pediatric Cancer and Precision Medicine
in Cancer Research Catalyst Guest Blog Post
New NIH Brochure Outlines the Value of Pediatric Palliative Care
Palliative care represents the comprehensive treatment of the discomfort, symptoms, and stress associated with serious illness. It is a key part of care for children living with serious illnesses and an important source of support for their families.
The National Institute of Nursing Research (NINR), part of the National Institutes of Health (NIH) has recently developed a brochure highlighting the value of palliative care for children as part of their new Conversations Matter® Campaign.
Peter C. Adamson, MD, former PCWG Steering Committee Member, appointed to President Obama's National Cancer Advisory Board
Dr. Peter Adamson, attending physician in the Division of Oncology at The Children’s Hospital of Philadelphia (CHOP), has been named by President Obama to the National Cancer Advisory Board. Dr. Adamson has been chair of the Children's Oncology Group, supported by the National Cancer Institute (NCI), since 2010. Read more about his appointment.
PCWG Chairperson, Garrett Brodeur, MD, Honored with Children's Hospital of Philadelphia Pitcher of Hope Award
Dr. Garrett Brodeur, PCWG chairperson, was the 2015 recipient of the Children's Hospital of Philadelphia Pitcher of Hope Award. The award is given out by CHOP annually during its Alex's Lemonade Stand "Lemonade Days" events to a recipient in the division of oncology who has positively impacted the field of pediatric oncology.
Margaret Foti, PhD, MD (hc), Receives the 2015 Children’s Champion Award from The Children’s Hospital of Philadelphia
Margaret Foti, PhD, MD (hc), chief executive officer of the AACR, was recognized with the Children’s Champion Award for her outstanding pediatric cancer advocacy efforts, at the PCWG town mall meeting in Philadelphia, Sunday, April 19, during the AACR Annual Meeting 2015.
FDA Approves First Immunotherapy for Children With Cancer
There has been a series of immunotherapy approvals since the end of last year, and following this trend, on March 10, we hit yet another milestone when the U.S. Food and Drug Administration (FDA) approved dinutuximab (Unituxin) for the treatment of pediatric patients with high-risk neuroblastoma. The drug was approved for use in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA). Dinutuximab is the first approved immunotherapy for pediatric cancer, and third therapy overall to be first approved for pediatric cancer by the FDA. Read more about it on Cancer Research Catalyst.
Scott M. Lippman, MD, Issues Guest Blog Post Concerning Cancer Prevention in Children
Read "Prophylactic Tonsillectomy in Childhood to Prevent Tonsillitis May Reduce the Risk for HPV-related Oropharyngeal Cancer" on Cancer Research Catalyst.
AACR Releases Cancer Research Catalyst Blog Post on the Importance of Pediatric Cancer Research
Through think tanks, special conferences, and its Pediatric Cancer Working Group, the AACR is taking steps to establish childhood cancer research as a global priority. Read "Seizing the Moment: Ongoing Pediatric Cancer Research May Hold Key to Finding Cancer Cures" on Cancer Research Catalyst.